---
layout: post
title:  Novel type II diabetes and NASH drugs.
date:   2019-09-05 07:30:00
categories: funding
comments: True


---

Co-PIs: Tim Peterson, [Brian Finck](https://diabetesresearchcenter.dom.wustl.edu/brian-n-finck-ph-d/)



Our company, [Bio-I/O](http://bioio.tech), was recently awarded a [fast-track STTR grant](https://sbir.nih.gov/funding) from the NIDDK for Novel type II diabetes and non-alcohlic steatohepatitis (NASH) drugs we are developing.




